Humana to Divest Minority Interest in Gentiva

Fried Frank is advising CenterWell Health Services, Inc., a subsidiary of Humana Inc., on its agreement, with a consortium of investors, to divest all or substantially all of its minority interest in Gentiva, the nation's leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana's minority interest stake at approximately $900 million. Read Humana's press release for more on the transaction, which is expected to close in the third quarter of 2026.

This transaction is a result of Humana's earlier acquisition of the remaining interest in Kindred at Home (KAH) in 2021 and its agreement to divest a majority interest in the Hospice and Personal Care divisions of Humana's Kindred at Home subsidiary (KAH Hospice) to private investment firm Clayton, Dubilier & Rice in 2022, matters in which Fried Frank also advised Humana.

The Fried Frank team is led by M&A and private equity partners Philip Richter and Alison McCormick and includes tax partner Shane C. Hoffmann and M&A and private equity associate Brianna N. Schacter.

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm's data policy page for further information.